INSMED INC (INSM)

Overview Price 5.00 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $5.00 Daily Range $0.00 - $0.00 52-Week Range $2.64 - $13.50 Volume 0 Insmed Pharmaceuticals is a development stage pharmaceutical company that is developing drugs to treat metabolic and endocrine diseases associated with insulin resistance. The company's first drug candidate, INS-1, is currently targeted towards the treatment of type 2 diabetes and polycystic ovary syndrome. The company is currently conducting multi-center phase II clinical trials for both indications. The company's objective is to establish a leading position in the treatment of metabolic and endocrine diseases. Other Resources for INSM Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. Insmed Pharmaceuticals is a development stage pharmaceutical company that is developing drugs to treat metabolic and endocrine diseases associated with insulin resistance. The company's first drug candidate, INS-1, iscurrently targeted towards the treatment of type 2 diabetes and polycysticovary syndrome. The company is currently conducting multi-center phase II clinical trials for both indications. The company's objective is to establish a leading position in the treatment of metabolic andendocrine diseases.   Brokerage Analyst Recommendations 1 Brokerage Firms Covering INSM   Strong Buy 1 Buy 0 Hold 0 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1   INSM Ratings: BUY  SELL  HOLD INSM Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 1 Buy 0 Sell   Top Buy Analysis BUY: INSM Company: INSMED INC Points: -7.05 Start Price: $5.35 Start Date: 02/02/2012 9:54 PM r0bert P&P Score: 4.45 Recs: FDA will release hold on its drug for CF Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
MTnews	0.00	08/02/11	Threat Of The U.S. Defaulting	0
stocklook	4.04	12/23/09	Penny Stocks With Promising Futures	3	12/25/09

Commentary

BUY: INSMED INC (INSM) Start Price: $5.35 Points: -7.05 Created: 02/02/2012 FDA will release hold on its drug for CF Comments: 0 | Comment r0bert Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
r0bert	4.45	BUY	Three to Six Months	02/02/2012	$5.35	$5.00 (-2.72%)	-6.54%	+0.50%	-7.05	view close